Shopping Cart
Remove All
Your shopping cart is currently empty
Soficitinib (Compound 20) is a selective inhibitor targeting tyrosine kinase 2 (TYK2) and Janus kinase 2 (JAK2), with IC50 values of 0.5 nM and 1.2 nM, respectively. It holds potential for research in autoimmune diseases such as psoriasis and rheumatoid arthritis, as well as inflammatory conditions.


| Description | Soficitinib (Compound 20) is a selective inhibitor targeting tyrosine kinase 2 (TYK2) and Janus kinase 2 (JAK2), with IC50 values of 0.5 nM and 1.2 nM, respectively. It holds potential for research in autoimmune diseases such as psoriasis and rheumatoid arthritis, as well as inflammatory conditions. |
| Molecular Weight | 400.87 |
| Formula | C18H21ClN8O |
| Cas No. | 2574524-67-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.